Tanja Gromke

868 total citations
17 papers, 374 citations indexed

About

Tanja Gromke is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Tanja Gromke has authored 17 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Hematology and 4 papers in Molecular Biology. Recurrent topics in Tanja Gromke's work include Hematopoietic Stem Cell Transplantation (6 papers), GDF15 and Related Biomarkers (3 papers) and Acute Myeloid Leukemia Research (2 papers). Tanja Gromke is often cited by papers focused on Hematopoietic Stem Cell Transplantation (6 papers), GDF15 and Related Biomarkers (3 papers) and Acute Myeloid Leukemia Research (2 papers). Tanja Gromke collaborates with scholars based in Germany, Switzerland and Spain. Tanja Gromke's co-authors include Dietrich W. Beelen, Rudolf Trenschel, Michael Koldehoff, Markus Ditschkowski, Ahmet Elmaağaclı, Nina K. Steckel, Hellmut Ottinger, Peter A. Horn, Yael Hegerfeldt and Susanne Schnittger and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Tanja Gromke

16 papers receiving 369 citations

Peers

Tanja Gromke
Ryoko Yamasaki Japan
Evren Özdemir Türkiye
K. Delavigne France
Judith Landman France
Yuichiro Nawa Japan
Jusnara Begum United Kingdom
Arianna De Matteis Italy
Reiki Ogasawara Japan
R. de Paz Spain
Romain Lévy France
Ryoko Yamasaki Japan
Tanja Gromke
Citations per year, relative to Tanja Gromke Tanja Gromke (= 1×) peers Ryoko Yamasaki

Countries citing papers authored by Tanja Gromke

Since Specialization
Citations

This map shows the geographic impact of Tanja Gromke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanja Gromke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanja Gromke more than expected).

Fields of papers citing papers by Tanja Gromke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanja Gromke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanja Gromke. The network helps show where Tanja Gromke may publish in the future.

Co-authorship network of co-authors of Tanja Gromke

This figure shows the co-authorship network connecting the top 25 collaborators of Tanja Gromke. A scholar is included among the top collaborators of Tanja Gromke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanja Gromke. Tanja Gromke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Carlino, Matteo S., Reinhard Dummer, Tanja Gromke, et al.. (2025). A first-in-human study of DYP688, an antibody drug conjugate delivering a direct Gq/11 inhibitor, in patients with metastatic uveal melanoma (MUM) and other GNAQ/11 mutant melanomas.. Journal of Clinical Oncology. 43(16_suppl). 9509–9509. 1 indexed citations
2.
Lever, M. J., Simon Bogner, Fabian Mairinger, et al.. (2024). Prognostic value of clinical and radiomic parameters in patients with liver metastases from uveal melanoma. Pigment Cell & Melanoma Research. 37(6). 831–838.
3.
Melero, Ignacio, Maria J. de Miguel, Guillermo de Velasco, et al.. (2024). Effects of neutralization of tumor-derived immunosuppressant GDF-15 on anti-PD-1 activity in anti-PD-(L)1 relapsed/refractory non-squamous NSCLC, urothelial, and hepatocellular cancer.. Journal of Clinical Oncology. 42(16_suppl). 2513–2513. 2 indexed citations
4.
5.
Melero, Ignacio, Maria J. de Miguel, Guzmán Alonso, et al.. (2023). Initial results from the phase 2A trial of visugromab (CTL-002) + nivolumab in advanced/metastatic anti-PD1/-L1 relapsed/refractory solid tumors (The GDFATHER-TRIAL).. Journal of Clinical Oncology. 41(16_suppl). 2501–2501. 7 indexed citations
6.
7.
Melero, Ignacio, Emiliano Calvo, Reinhard Dummer, et al.. (2021). A phase I, first-in-human clinical trial of the GDF-15 neutralizing antibody CTL-002 in subjects with advanced-stage solid tumors (ACRONYM: GDFATHER).. Journal of Clinical Oncology. 39(15_suppl). TPS2658–TPS2658. 5 indexed citations
8.
Hanoun, Christine, Hildegard Lax, Nils Lehmann, et al.. (2020). Fertility preservation and fulfillment of parenthood after treatment of hematological malignancies: results from the ‘Aftercare in Blood Cancer Survivors’ (ABC) study. International Journal of Clinical Oncology. 25(6). 1187–1194. 1 indexed citations
9.
Adam, Birgit, Michael Koldehoff, Markus Ditschkowski, et al.. (2016). Endoscopic and Histological Findings Are Predicted by Fecal Calprotectin in Acute Intestinal Graft-Versus-Host-Disease. Digestive Diseases and Sciences. 61(7). 2019–2026. 6 indexed citations
10.
Elmaağaclı, Ahmet, Markus Ditschkowski, Nina K. Steckel, et al.. (2014). Human chorionic gonadotropin and indolamine 2,3-dioxygenase in patients with GVHD. Bone Marrow Transplantation. 49(6). 800–805. 8 indexed citations
11.
Ditschkowski, Markus, Ahmet Elmaağaclı, Michael Koldehoff, et al.. (2013). Bronchiolitis obliterans after allogeneic hematopoietic SCT: further insight—new perspectives?. Bone Marrow Transplantation. 48(9). 1224–1229. 33 indexed citations
12.
13.
14.
Elmaağaclı, Ahmet, Nina K. Steckel, Michael Koldehoff, et al.. (2011). Early Cytomegalovirus Replication After Allogeneic Stem Cell Transplantation Is Associated With a Dramatically Reduced Relapse Risk in Acute Myeloid Leukemia Patients: Evidence for a Putative Virus-Versus-Leukemia Effect. Biology of Blood and Marrow Transplantation. 17(2). S161–S161. 1 indexed citations
15.
Hilgendorf, Inken, Daniel Wolff, Tanja Gromke, et al.. (2010). Retrospective analysis of treosulfan-based conditioning in comparison with standard conditioning in patients with myelodysplastic syndrome. Bone Marrow Transplantation. 46(4). 502–509. 11 indexed citations
16.
Beelen, Dietrich W., Tanja Gromke, Rudolf Trenschel, et al.. (2008). Treosulfan Compared to Total Body Irradiation-Based Preparative Regimens Before Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia : A Retrospective Long-Term Study.. Blood. 112(11). 2149–2149. 2 indexed citations
17.
Rakatzi, Irini, et al.. (2006). Differential phosphorylation of IRS-1 and IRS-2 by insulin and IGF-I receptors. Archives of Physiology and Biochemistry. 112(1). 37–47. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryoko Yamasaki Breakdown of academic impact, for papers by Evren Özdemir Breakdown of academic impact, for papers by K. Delavigne Breakdown of academic impact, for papers by Judith Landman Breakdown of academic impact, for papers by Yuichiro Nawa Breakdown of academic impact, for papers by Jusnara Begum Breakdown of academic impact, for papers by Arianna De Matteis Breakdown of academic impact, for papers by Reiki Ogasawara Breakdown of academic impact, for papers by R. de Paz Breakdown of academic impact, for papers by Romain Lévy
Rankless by CCL
2026